Showing results (71-80 of 441) with videos related to
Sort By:
Pageof 45
Neuro-Oncology|October 31, 2015
Immunotherapy for neuro-oncology: the critical rationale for combinatorial therapyDavid A Reardon, Mark R Gilbert, Wolfgang Wick, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2007
Chemoradiotherapy in malignant glioma: standard of care and future directionsRoger Stupp, Monika E Hegi, Mark R Gilbert, et al.Cancer Medicine|July 8, 2023
Clinical outcome assessment trends in clinical trials-Contrasting oncology and non-oncology trialsYeonju Kim, Mark R Gilbert, Terri S Armstrong, et al.Journal of Neuro-Oncology|November 26, 2009
Seizure risk in brain tumor patients with conversion to generic levetiracetamTerri S Armstrong, Shauna Choi, Julie Walker, et al.Journal of Voice : Official Journal of the Voice Foundation|February 5, 2017
The VHI-10 and VHI Item Reduction Translations-Are we all Speaking the Same Language?Mark R Gilbert, Jackie L Gartner-Schmidt, Clark A RosenNeuro-Oncology Practice|December 29, 2025
Clinical outcome assessment trends in neuro-oncology trialsYeonju Kim, Mark R Gilbert, Terri S Armstrong, et al.Journal of the National Cancer Institute|September 26, 2024
Disparities in the availability of and access to neuro-oncology trial-supporting infrastructure in the United StatesYeonju Kim, Terri S Armstrong, Mark R Gilbert, et al.Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|August 27, 2015
Early T Stage Salivary Duct Carcinoma: Outcomes and Implications for Patient CounselingNicole C Schmitt, Arun Sharma, Mark R Gilbert, et al.Frontiers in Cellular Neuroscience|October 31, 2017
Targeting WNT Signaling for Multifaceted Glioblastoma TherapyMatthew McCord, Yoh-Suke Mukouyama, Mark R Gilbert, et al.Neuro-Oncology|February 9, 2023
A critical analysis of neuro-oncology clinical trialsYeonju Kim, Terri S Armstrong, Mark R Gilbert, et al.Pageof 45